Last edition
News about "glycemic control "
Roche Reports Positive Phase 2 Results for Enicepatide
Roche has announced positive phase 2 results for dual GLP-1/GIP receptor agonist enicepatide in people living with Type 2 Diabetes and overweight or obesity.
Glycemic Control | 23/09/2026 | By News Bureau | 106
Biocon Biologics and Civica Launch Private-Label Insulin Glargine in the US
The multi-year transformational agreement between Biocon Biologics and Civica creates an exclusive distributorship arrangement where Biocon Biologics will manufacture and supply Insulin Glargine medicine to Civica, and Civica will commercialise under Biocon Biologics’ existing marketing approval.
Glycemic Control | 21/10/2025 | By Dineshwori | 333
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy